FIELD: chemistry.
SUBSTANCE: invention relates to novel IAP inhibitors of general formula , where Q, X1, X2, Y, Z1, Z2, Z3, Z4, R1, R2, R3, R3', R4, R4', R5, R6, and R6', and n assume values given in the description.
EFFECT: compounds can be used as therapeutic agents for treating malignant growths.
15 cl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
IAP INHIBITORS | 2008 |
|
RU2491276C2 |
IMIDAZOPYRIDINE IAP INHIBITORS | 2007 |
|
RU2466131C2 |
IAP INHIBITORS | 2005 |
|
RU2401840C2 |
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS | 2012 |
|
RU2569635C9 |
N-PHENYL-DIOXOX-HYDROPYRIMIDINE USED AS HEPATITIS C VIRUS INHIBITOR (HCV) | 2008 |
|
RU2542099C2 |
BETA-LACTAMASE INHIBITORS | 2013 |
|
RU2654692C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505540C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773346C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505539C2 |
Authors
Dates
2012-05-20—Published
2006-12-19—Filed